Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Clinical trial NCT05111197 · UNKNOWN

Trial details

NCT number: NCT05111197
Sponsor: Institut Cancerologie de l'Ouest
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer

Start date: 2022-01-12
Primary completion: 2025-01-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.